Discover the technical capabilities of the Absolute Q®
Do you have a complex question that you think digital PCR could answer? Learn more about the Absolute Q’s unique design and microfluidic array partitioning technology to discover how digital PCR can enhance your research efforts.
In this study, we characterize the LoD of the Combinati |Q| SARS-CoV-2 RT-dPCR Triplex Kit by diluting reference materials into a pooled negative matrix to determine the lowest concentration at which the assay can reliably identify the sample as containing SARS-CoV-2 targets.
Reverse transcription allows the detection and quantification of RNA. Here, we demonstrate a true 1-step RT-dPCR workflow on the Absolute Q by quantifying SARS-CoV-2 targets in under 90 minutes.
The unique architecture of the Absolute Q and the MAP16 allows flexibility that is not offered by any other dPCR platform. See how assay optimization can be done efficiently using a single consumable.
Read about how the Applied Biosystems™ TaqMan® Liquid Biopsy dPCR assays were used to detect 5 hot-spot cancer mutations on the Combinati Absolute Q platform.